Zymeworks Stock Soars 52% on Premium Offer by All Blue Falcons
(Zymeworks) Shares of Zymeworks Inc. rose more than 52% on Friday after receiving a takeover offer of $10.50 per share. The cash offer values the developer of cancer antibody therapies…
Zymeworks